Navigation Links
Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
Date:11/27/2007

, 73 of the approximately 100 clinical sites in the SPEAR study are active, and the balance of sites is to be opened as planned. Based on recent enrollment data, Poniard estimates that it will complete enrollment in 3Q 2008.

Poniard continues to anticipate filing a New Drug Application with the FDA in 2009. The Company received fast track designation from the FDA for picoplatin for the second-line treatment of refractory or resistant SCLC, allowing a rolling NDA submission.

"We are encouraged by the enrollment pace at our sites that have been open for three months or more, because these are enrolling patients better than at the anticipated rate," added Dr. McMahon. "Based on our prior trial in SCLC, and our experience at many of our active SPEAR sites, we anticipate an acceleration of enrollment as more sites are open longer and new sites are opened. In addition to patients that have already enrolled, we are following approximately 200 additional SCLC patients currently receiving first-line treatment who may be eligible to participate in the SPEAR trial."

Phase 2 CRC Trial:

Poniard is also evaluating intravenous picoplatin as a replacement for oxaliplatin in an ongoing Phase 2 trial for the first-line treatment of metastatic CRC with picoplatin in combination with 5-fluorouracil and leucovorin, or FOLPI, compared to the standard-of-care FOLFOX regimen, including oxaliplatin, in a 100-patient randomized trial.

The Company has opened 18 of the planned 23 clinical sites and is enrolling patients in this randomized trial, which is evaluating picoplatin as a first-line agent in CRC. The Company is treating patients in the trial and expects to fully enroll the trial in the first half of 2008. Poniard expects to present clinical data from the Phase 1 and Phase 2 CRC trials at scientific meetings throughout 2008.

Phase 2 HRPC Trial:

Intravenous picoplatin also is under evaluation in an ongoing Phase 2 trial for the treatment
'/>"/>

SOURCE Poniard Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... and LOS ANGELES , Aug. ... DGX ), the world,s leading provider of diagnostic ... the previously announced acquisition of MemorialCare Health System,s ... a result of the transaction, patients and physicians ... innovative services and network of nearly 200 patient ...
(Date:8/4/2015)... , Aug. 4, 2015  The Pittsburgh Life Sciences ... firm, announced today that one of its portfolio companies, ... their Flex ® Robotic System in the U.S.  ... more proud of Medrobotics," said John W. Manzetti ... a very long way since spinning out of The ...
(Date:8/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... $18.9 million for the three and six months ended ... of $12.1 million and $43.4 million for the same ... driven primarily by the more than $90 million of ... the upfront payment from Bayer to license  ISIS-FXI Rx ...
Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Members receiving ... quality care metrics – at a cost that is nine percent lower -- than ... Cross Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, ...
(Date:8/4/2015)... ... ... They say a picture is worth a thousand words, and when it ... be essential. StayWell, a health solutions company, announced today it will license KramesArt™ for ... by physicians and other health care providers for more than 40 years and are ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... with “Dr. Google” before calling a physician. In an effort to share more ... health care provider in Pennsylvania to publicly share patient satisfaction ratings and comments ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... design, product packaging, and fulfillment services, joined over 200 other Long Island-based corporations ... held on Tuesday, July 28th at Jones Beach State Park in Wantagh, New ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients ... now offered by the world renowned Beverly Hills facelift surgeon , Dr. ... cosmetic surgery techniques helps individuals to achieve an outer appearance that meets their ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
... WASHINGTON, June 4 As talk of ... sales bring up,worries about the nation,s economic health, ... are stressed and anxious about,their financial future. An ... that,two-thirds (66 percent) of Americans identify the economy ...
... fall out as a result of inflammation and subsequent ... Agnes Berendsen has investigated a possible solution to this ... she has studied the regeneration of the periodontal ligament ... model she has developed appears to be promising for ...
... such as periods of high temperature, is one way ... like cryptosporidiosis, an intestinal disease that causes upset stomach ... model that takes into account weather and other factors ... ill during an outbreak. With this model they show ...
... 4, 2008 -- Bioengineers at Rice University have discovered ... experience more than a half-mile beneath the ocean,s surface ... nearly all of the properties of natural cartilage. The ... provide relief for thousands of arthritis sufferers. , "This ...
... DALLAS June 3, 2008 Young adults who abuse ... attack, UT Southwestern Medical Center researchers have found. , In ... Alcohol Dependence , researchers examined data from more than 3 ... 2000 through 2003 in Texas and found a relationship between ...
... who took part in two health surveys carried out a ... published in the latest Journal of Advanced Nursing. , Thirteen ... second survey and a further five per cent reported problems ... were more likely to report multiple psychological problems and health ...
Cached Medicine News:Health News:Economy and Money Top Causes of Stress for Americans 2Health News:Economy and Money Top Causes of Stress for Americans 3Health News:Saving teeth by using periodontal ligament regeneration 2Health News:Weather, stomach bugs and climate change: Refining the model 2Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 2Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 3Health News:Study finds link between amphetamine abuse and heart attacks in young adults 2Health News:Nearly 1 in 5 teenagers admit eating problems, but anxiety is a bigger problem than appearance 2
Microforceps: Spaid Pic Forceps...
End-gripping forceps with small, concentric rings on each tip. For general purpose membrane grasping, particularly thin membranes, or grasping membranes adherent to the retinal surface....
... design and developmerit of systems for the ... is pleased to present its latest system ... in one compact system. The D.O.R.C. VFI/VFE ... such as silicone oil, with viscosities of ...
... System provides the bright, white illumination ... remarkable difference: HEXON utilizes a metal ... source of high quality illumination. This ... consistency which is well suited for ...
Medicine Products: